Rebalancing agents represent a novel therapeutic class in haemophilia, designed to restore the deficient thrombin generation that underlies bleeding. Unlike factor replacement or factor VIII mimetic therapies,... En savoir plus |
Version PDF
|
Imprimer l'abstract
Research and Practice in Thrombosis and Haemostasis 2026; 10(2): 103384
Joint bleeds for persons with hemophilia are characteristic and can lead to hemophilic arthropathy, primarily in the ankles, knees, and elbows. The Hemophilia Joint Health Score (HJHS) is a validated physical... En savoir plus |
Version PDF
|
Imprimer l'abstract
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2026 Jan
Life expectancy in people with haemophilia (PWH) has risen markedly, creating an ageing population with both age-related diseases and sequelae of historical treatment eras. Chronic hepatitis C virus (HCV)... En savoir plus
|
Free Full-text
Hemophilia is no longer regarded solely as a male disorder; female carriers are increasingly attracting the attention of the scientific community due to the common, albeit overlooked, bleeding tendency... En savoir plus
|
Free Full-text
